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The traditional view of macrolide antibiotics as plugs
inside the ribosomal nascent peptide exit tunnel
(NPET) has lately been challenged in favor of a
more complex, heterogeneous mechanism, where
drug-peptide interactions determine the fate of a
translating ribosome. To investigate these highly
dynamic processes, we applied single-molecule
tracking of elongating ribosomes during inhibition
of elongation by erythromycin of several nascent
chains, including ErmCL and H-NS, which were
shown to be, respectively, sensitive and resistant to
erythromycin. Peptide sequence-specific changes
were observed in translation elongation dynamics
in the presence of a macrolide-obstructed NPET.
Elongation rates were not severely inhibited in
general by the presence of the drug; instead, stalls
or pauses were observed as abrupt events. The
dynamic pathways of nascent-chain-dependent
elongation pausing in the presence of macrolides
determine the fate of the translating ribosome
stalling or readthrough.
INTRODUCTION
The peptide elongation cycle is guided by the ribosome and
involves sequential selection of aminoacyl-tRNAs, the peptidyl
transfer reaction, and subsequent translocation by one codon
on the mRNA. These steps are tuned by evolution to obtain an
optimal balance between rate and accuracy of peptide synthesis
to maximize cell growth rate (Johansson et al., 2012). At the
same time, the rate of peptide synthesis must be tunable both
globally (to respond to changing environments) and locally
(for regulatory reasons, such as for the formation of protein
secondary structures or regulatory rearrangements of mRNA
structure). However, the mechanistic underpinnings of transla-
tional regulation remain unclear.
The ribosomal nascent peptide exit tunnel (NPET) plays an
active role in translational control. All nascent polypeptides
must traverse and exit this tunnel, which extends 120 A˚ through1534 Cell Reports 7, 1534–1546, June 12, 2014 ª2014 The Authorsthe large (50S in bacteria) subunit from the peptidyl transferase
center (PTC) to the subunit exterior; this encompasses 30–40
amino acids of the nascent chain during protein synthesis.
Recent data have shown that interactions of the nascent chain
with the exit tunnel can modulate the rate of protein synthesis,
leading to pausing or stalling of translational elongation (Marin,
2008; Wilson and Beckmann, 2011). Small-molecule ligands
that bind within the exit tunnel can also induce stalling of trans-
lation elongation. Macrolide antibiotics, which include the repre-
sentative drug erythromycin, bind in the exit tunnel near the PTC,
contacting RNA (A2058 and A2059) and protein (L4 and L22)
residues (Dunkle et al., 2010). Traditionally, erythromycin and
other macrolides have been considered to work as simple plugs
in the NPET, blocking passage of the nascent peptide and
inhibiting further peptide synthesis. This would eventually lead
to peptidyl-tRNA drop-off from the ribosome that could deplete
the cell of available tRNAs (Menninger and Otto, 1982).
This simple mechanism is challenged by recent experiments
that underscore the interactions of the nascent chain, tunnel,
and macrolide in translational elongation. Translation in the
presence of erythromycin of a short regulatory leader peptide,
ErmCL, in the erythromycin resistance ermC cassette results in
a stalled ribosome complex, with the peptidyl-tRNA stably
bound. The stalled complex facilitates rearrangement of an
immediate downstream mRNA secondary structure, opening
up a normally hidden ribosome binding site on the downstream
ermC methyltransferase gene, thus providing macrolide
resistance to the cell (Weisblum, 1995). This regulation requires
a specific amino acid sequence in the ErmCL, suggesting
sequence-specific interactions among the nascent peptide,
ribosome, and drug (Vazquez-Laslop et al., 2008).
The discovery of peptide sequences that are resistant to
macrolides provides further evidence for sequence-specific
interactions of the nascent chain with macrolides (Tenson and
Mankin, 2001). Translation of a penta-peptide encoding open
reading frame (ORF) inside the E. coli 23S rRNA causes low-level
erythromycin resistance by a mechanism in which the short
nascent peptide evicts the drug (Lovmar et al., 2006); the length
and the specific amino acid identities of the short peptide are
crucial for resistance efficiency.
Finally, although macrolides occupy space in the tunnel
normally available to the nascent peptide, they do not occlude
the tunnel completely (Bulkley et al., 2010; Dunkle et al., 2010;
Schlu¨nzen et al., 2001; Tu et al., 2005). Recently, Kannan et al.
(2012) showed that certain peptide sequences can allow full
translation by ribosomes that most likely retain erythromycin
bound inside the NPET, with the nascent peptide passing by
the drug during elongation.
Overall, these results suggest a complex interplay between
the nascent peptide and the exit tunnel. How cofactor-
dependent (e.g., ErmCL) or -independent (e.g., SecM; Wilson
and Beckmann, 2011) stalling is mediated and whether specific
interactions are needed between the NPET, peptide, and, if
applicable, the drug molecule, to produce stalling remain unan-
swered questions. How these two general pathways for stalling
compare remains unclear: recent single-molecule dynamics ex-
periments have shown that SecM-induced stalling occurs grad-
ually through a series of key nascent peptide-tunnel interactions,
leading to a distribution of final stall sites (Tsai et al., 2014, in this
issue of Cell Reports). During elongation on macrolide-bound
ribosomes, the outcome may depend not only on the macrolide
structure (Kannan and Mankin, 2011), but also on the specific
amino acid sequence of the peptide being synthesized.
To delineate and distinguish these distinct mechanisms of
macrolide sensitivity and resistance, we applied single-molecule
fluorescence to observe translation directly in real time. Our
results reveal distinct compositional and conformational
dynamics of the translating ribosome in the presence of macro-
lides, depending on the specific amino acid sequence of the
nascent peptide. The dynamic pathways of nascent-chain-
dependent elongation pausing in the presence of macrolides
determine the fate of the translating ribosome.
RESULTS
Intersubunit FRET Signal for Real-Time Tracking
of Elongation Dynamics on ermCL
To follow elongation dynamics directly, we used ribosomal inter-
subunit Fo¨rster resonance energy transfer (FRET) to track the
ribosome movement in real time while it translates an
mRNA. With the 30S and the 50S subunits site specifically
labeled on helix 44 on 16S rRNA with a fluorescent donor dye
(Cy3 or Cy3B) and helix 101 on 23S rRNA labeled with an
acceptor dye (Cy5), FRET efficiency between the two dyes
upon excitation of the donor depends on the rotation of the
two subunits with respect to each other (Marshall et al., 2008).
During one elongation cycle, the two subunits start in a nonro-
tated state, to which the EF-Tu,GTP,aa-tRNA ternary complex
(TC) binds to the vacant A site, EF-Tu-bound GTP is hydrolyzed
and peptidyl transfer from P-site tRNA to the A-site aa-tRNA oc-
curs. This nonrotated state results in high FRET between the two
dyes (Figure 1A). After peptidyl transfer, the two subunits rotate
610 degrees relative to each other, resulting in a longer dis-
tance between the dyes and thus lower FRET efficiency. When
translocation of the tRNAs and mRNA on the ribosome is
completed through the action of EF-G, the two subunits rotate
back to their original position—the high-FRET state—and the
cycle is completed (Figure 1A). Assuming that practically all
these FRET cycles are productive, i.e., an amino acid is incorpo-
rated, this signal allows us to track ribosomemovement and sub-
steps along the mRNA with codon resolution. The validity of thisCsystem was previously demonstrated on simple mRNA models
containing a few different codons (Aitken and Puglisi, 2010;
Chen et al., 2013; Tsai et al., 2013) that correspond to purified
tRNAs. To follow elongation on natural heteropolymeric mRNAs,
such as ermCL, we prepared a semipurified aaRS mixture to
charge total E. coli tRNA. The complete set of aa-tRNAs was
then purified and used together with the intersubunit FRET signal
to allow real-time tracking of elongation dynamics on any mRNA
sequence.
To probe the translation elongation dynamics on ermCL
mRNA, we employed single-molecule analysis of intersubunit
FRET during translation. We delivered a mixture of EF-G, a set
of total aa-tRNA,GTP,EF-Tu TCs along with 50S subunits
labeled with a fluorescence quencher (black-hole quencher
[BHQ]; Chen et al., 2012) to preinitiation [Cy3B]30S complexes
(PICs, consisting of mRNA, fMet-tRNAfMet, IF2-GTP, and 30S
subunits), formed on ermCL mRNA immobilized on a micro-
scope slide (Figure 1B). The fluorescence intensity of individual
[Cy3B]30S subunits were recorded over time, and individual
time traces were subsequently analyzed (Figure 1C). The use
of BHQ rather than the traditional Cy5 as FRET acceptor allows
the use of Cy5 to label other reagents, such as tRNA or protein
factors (Chen et al., 2013), and extends the observation window
for ribosome dynamics to the lifetime of the longer-lived Cy3B
dye (up to several minutes). The latter was necessary when
tracking the elongation dynamics through pausing and stalling
events. As can be seen in the survival plot (Figure 1D), where
the percentage of elongating ribosomes at each codon is shown,
a good proportion (>20%) of ribosomes translate the whole
ermCL message within the Cy3B lifetime.
With subsaturating concentrations of TCs and EF-G, the life-
times of the nonrotated state (high-FRET) and the rotated state
(low-FRET) are inversely proportional to the TC and EF-G con-
centrations, respectively. At 1.5 mM total aa-tRNA, nonrotated
lifetimes are around 10 s (Figure 1E); thus, an effective associa-
tion rate constant of roughly 2 mM1s1 can be estimated from
the relative abundances of tRNA reading the ermCL message
(Dong et al., 1996). This is in agreement with previously esti-
mated TC association rates to immobilized ribosomes (Aitken
and Puglisi, 2010) and hence suggests that the total aa-tRNA
preparation is functional. The nonrotated and rotated state
lifetimes are fairly constant throughout the whole message (Fig-
ure 1E). The slightly higher lifetimes of the nonrotated state at
later codons might be due to relatively lower abundance of
several of the respective tRNA isoacceptors in the E. coli-
extracted total tRNA (e.g., tRNAPro3), the tRNAs corresponding
to the last six codons being on average 1.8-fold lower in concen-
tration in E. coli cells (Dong et al., 1996) than the ones reading the
first 12. The waiting times in the rotated state are constant
throughout the mRNA, consistent with constant EF-G concen-
tration during the experiment and suggesting no significant
energetic barriers to translocation at a specific codon.
Erythromycin Induced Ribosome Stalling on ermCL
The presence of saturating concentrations of erythromycin
(1 mM) drastically changes the translation dynamics of ermCL
(Figure 2A). The survival plot (Figure 2B) shows a clear inhibition
of translation elongation, with an abrupt halt around theell Reports 7, 1534–1546, June 12, 2014 ª2014 The Authors 1535
Figure 1. Tracking Elongation Dynamics of Single Ribosomes in Real Time
(A) Site-specific fluorescence labeling of the ribosomal subunits allow observations of changes in intersubunit FRET as the relative rotation of the subunits
changes during an elongation cycle. A cycle from nonrotated to rotated state and back represents the ribosome translating one codon.
(B) Tracking of single elongating ribosomes was done using a TIRF microscope set-up with mRNA-immobilized 30S PICs onto which a mixture of EF-G, a set of
total aa-tRNA,GTP,EF-Tu ternary complexes along with 50S subunits was delivered.
(C) The dynamics of ermCL translation was followed in real time using intersubunit FRET between Cy3B and BHQ. Transition from low Cy3B intensity (high FRET)
to high intensity (low FRET) and back to low intensity again reports on one elongation cycle, i.e., peptidyl transfer and subsequent translocation. When the ermCL
mRNA is completely translated, the ribosome stops in a nonrotated (low Cy3B intensity) state with the stop codon in A site.
(D) Survival plot showing the density of elongating ribosomes at each codon summarized from individual ermCL translation time traces (n = 152).
(E) Lifetimes of the rotated and nonrotated states for each individual codon calculated from individual time traces as shown in (C). Bars represent single
exponential fitting of the data ± SEM (n = 152).
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Figure 2. Effect of Erythromycin on ermCL Elongation Dynamics
(A) The dynamics of ermCL translation in presence of erythromycin was followed in real time using intersubunit FRET between Cy3B and BHQ. After translocation
on codon Ile9, positioning codon Ser10 in A site, further elongation is blocked.
(B) Left: survival plot summarized from individual ermCL translation time traces in presence of erythromycin (red). Right: lifetimes of the nonrotated state for each
individual codon during ermCL translation in presence of erythromycin (red). Data from Figures 1D and 1E are shown for comparison (blue). Bars represent single
exponential fitting of the data ± SEM (n = 103).
(C) Left: survival plot summarized from individual gp32 translation time traces in presence of erythromycin (blue). Right: lifetimes of the nonrotated state for each
individual codon during gp32 translation in presence of erythromycin (blue). Data from Figure 2B are shown for comparison (red). Bars represent single
exponential fitting of the data ± SEM (n = 98).
See also Figure S1.previously suggested stall site (27% of ribosomes stop specif-
ically at Ser10 codon in A site) (Vazquez-Laslop et al., 2008);
no ribosome proceeds beyond the Val12 codon. Elongation
kinetics in the presence of erythromycin is not disrupted during
the rotated state at any codons (Figure S1A) but is increased in
the nonrotated state at the stall site and beyond (Figure 2B).
When the concentration of erythromycin was halved (0.5 mM),
the same stalling pattern and elongation dynamics were seen
(Figure S1B). Because the average lifetimes are calculated only
from processive events (to exclude, e.g., abnormal dye
behavior), the lifetime of the nonrotated state at codon Ser10,
as reported in Figure 2B, does not include the long stalling times
as shown in the trace in Figure 2A. The same analysis, but
including the lifetime after the final state transition, results inCthe same trend (Figure S1C). Ninety-seven percent of the ribo-
somes reading to or beyond codon Ile9 in A site end in the non-
rotated state. This is consistent with previous results suggesting
that ribosomes stall after translocation to the Ser10 codon and
are incapable of catalyzing peptidyl transfer from tRNAIle in
P site to the following Ser-tRNASer (Vazquez-Laslop et al., 2008).
To compare erythromycin inhibition of ermCL translation to
that of a generic mRNA, we performed the same experiments
using the phage T4 gp32 mRNA. In absence of erythromycin,
translation occurs normally across more than 30 codons with
lifetimes for the nonrotated and rotated states as expected
from TC and EF-G concentrations (Tsai et al., 2014). The pres-
ence of erythromycin results in earlier elongation termination,
with no particular end state favorable (Figure 2C). The lifetimesell Reports 7, 1534–1546, June 12, 2014 ª2014 The Authors 1537
of the rotated (Figure 2C) and nonrotated (Figure S1E) states are
similar to the lifetimes on ermCL, with or without drug, but lack
the long-lived nonrotated state at the stall site of ermCL with
drug. Hence, the only clear signature of drug binding on this
generic mRNA is the early termination events, whereas elonga-
tion kinetics on these early codons is not significantly affected.
Peptide Sequence-Dependent ermCL Stalling
We next tested the effects of nascent chain mutations on
ermCL stalling. Prior biochemical experiments underscored
the importance of amino acids 6–9, whose mutation to Ala
abolished stalling at the Ser10 codon, whereas the identity of
the first codons, or the Ser10 codon, was shown not to be
important (Vazquez-Laslop et al., 2008). We performed dy-
namic translation elongation experiments on an ermCL mutant
where the Ile9 codon was changed to alanine (ermCL(I9A)); no
effect of the mutation was observed in the absence of erythro-
mycin, whereas in the presence of drug there was a decrease in
ribosomes stalled at codon 10 in the A site compared to wild-
type stalling (31% reaching codon Thr11, compared to 18%
for the wild-type sequence) (Figure S1D). There was a long
pause in the nonrotated state with codon 10 in the A site,
although this pause was shortened compared to wild-type
and allowed a larger fraction of ribosomes to continue elon-
gating. The relatively high lifetimes of the nonrotated state on
codons downstream of the stall site suggest that the drug is still
bound and compromises elongation dynamics subsequent to
codon 10.
One power of single-molecule experimentation is parsing
distinct pathways. To distinguish whether ribosomes that stall
or read through the stall site follow distinct mechanisms, we
parsed the individual time traces from the experiment with the
I9A mutant depending on whether the ribosomes pass the stall-
ing site or not. This analysis indicated no difference in elongation
kinetics on early codons (Figure S1F). There is no statistically
distinct event occurring before the ribosome reaches the stall
site that determines whether stalling occurs; thus, stalling of
ribosomes at codon 10 of ermCL(I9A) in presence of erythro-
mycin is stochastic.
Other mutations to the nascent chain within the critical
sequence gave similar results as ermCL(I9A) (Figure S1G). Muta-
tions of codon Ile6 (ermCL(I6A)) also showed reduced stalling, as
with ermCL(I9A), whereas changes of codon Ser10 ermCL(S10A)
had no effect on erythromycin-induced stalling, giving results
similar to wild-type ermCL. An ermCL(S5A) mutant displays
behavior intermediate to that of the wild-type/S10A and the
I6A/I9A mutants (Figure S1G). Thus, elongation was inhibited
by erythromycin on all of the ermCL variants tested, but only
the wild-type sequence and the S10A mutant displayed a clear
preference for elongation halt at codon Ser10. Elongation on
all ermCL variants results in longer-than-normal lifetimes of the
nonrotated state around the stall site and little or no effect on
the lifetimes of the rotated state. The overall reading length on
the ermCL mRNAs were in all cases longer than on the gp32
mRNA where elongation terminates preferentially around
codons 4–6. Thus, the ErmCL sequence allows translation of a
longer peptide (nine amino acids) than a random mRNA
sequence in the presence of erythromycin.1538 Cell Reports 7, 1534–1546, June 12, 2014 ª2014 The AuthorsTranslation inhibition by erythromycin onwild-type andmutant
ermCL was confirmed in a bulk assay probing for the time-
dependent production of full-length ErmCL peptides using
3H-labeled Lys (Supplemental Experimental Procedures). In
presence of erythromycin, the concentration of full-length
ErmCL peptide was 20% or less than in the control experiments
performed in absence of drug for all the sequence variants
described above (Figure S1H).
To determine whether the pause in elongation of ErmCL is
limited by TC binding, we measured elongation dynamics on
ermCL in the presence of erythromycin at 2-fold higher TC con-
centration; the lifetimes of the nonrotated state on the first few
codons decreased roughly 2-fold on both ermCL wild-type and
I9A mutant (Figure S1I). This indicates TC-association-limited
elongation kinetics and thus further shows that the elongation
dynamics on these first codons are not disrupted by drug pres-
ence. However, the lifetimes of long-lived pauses/stalls from
codon nine and onward were not affected by TC concentration,
demonstrating that the drug abruptly perturbs ribosome function
when a sufficiently long peptide has been synthesized. In the
absence of drug, the lifetimes of the nonrotated state over all
codons were on average decreased 2-fold (2.0 ± 0.2, Figure S1I)
at 2-fold higher TC concentration, as would also be expected
from TC association rate-limited elongation kinetics.
The ermCL-Stalled Complex Has a Perturbed aa-tRNA
Selective PTC
To characterize the stalling site further, we investigated tRNA
dynamics on codon Ser10. As the tRNASer isoacceptor reading
the wild-type AGC Ser10 codon is not readily labeled using our
approaches (Blanchard et al., 2004), we used an ermCL mRNA
with the nonessential Ser10 codon (Figure S1G; Vazquez-Laslop
et al., 2008) mutated to Lys (ermCL(S10K)), which should yield a
stalled complex with a Lys codon displayed in A site. The confor-
mational and compositional state of the ribosome during the stall
was probed by correlating binding of Cy5-labeled tRNALys with
the Cy3B/BHQ intersubunit FRET signal. To produce a TC mix
with the unlabeled wild-type tRNALys exchanged for [Cy5]
tRNALys, we charged and purified total tRNA while leaving out
the Lys amino acid. The purified DLys aa-tRNA mixture has
5% or lower concentration of Lys-tRNALys compared to our
purified total aa-tRNA preparation, as judged from the differ-
ences in lifetimes of the nonrotated state when a model mRNA,
consisting of six Phe-Lys repeats (6(FK) mRNA), is translated
on the TIRF microscope slide with normal or DLys aa-tRNA-con-
taining delivery mixes (Figure S2A). When this DLys aa-tRNA
mixture is delivered together with Lys-[Cy5]tRNALys and BHQ-
labeled 50S to the ermCL(S10K)-immobilized [Cy3B]30S-PICs,
we can follow simultaneously both the intersubunit FRET signal
as well as the decoding, translocations, and release of individual
Lys-[Cy5]tRNALys (Figure 3A). The majority of the Cy5-tRNALys
binding events (62%) occurred as predicted at the Lys10,
Lys18, and Lys19 codons (Figure 3B), with some background
of spurious events due to tRNA sampling. When erythromycin
was included in the delivery mix the [Cy5]tRNALys binding events
on Lys18, Lys19 disappeared. In addition, the Cy5-tRNALys
binding events on the Lys10 codon also disappeared almost
completely (Figure 3B), suggesting that, although the A site
Figure 3. Selective A Site in the ermCL-
Stalled Complex
(A) Dynamics of ermCL(S10K) translation, as
followed by intersubunit FRET and simultaneous
Lys-[Cy5]tRNALys binding. The time trace shows
how one ribosome translates the 19 codon
ermCL(S10K) message, followed in real time by
Cy3B/BHQ intersubunit FRET, whereas the Cy5
signal reports on the binding of Lys-tRNALys on
codons Lys10, Lys18, and Lys19. The experiment
was performed in the presence of DLys aa-tRNAs.
(B) Codon-specific Lys-[Cy5]tRNALys binding
densities summarized from individual time traces,
as shown in (A), when ermCL(S10K) is translated in
presence (n = 47) or absence (n = 56) of erythro-
mycin. The data have been normalized to the
highest number of molecules and the total number
of observed 70S IC formed in the separate
experiments.
(C) Dynamics of ermCL(S10F) translation, as
followed by intersubunit FRET and simultaneous
Phe-[Cy5]tRNAPhe binding. Left: the normalized
codon-specific Phe-[Cy5]tRNAPhe binding den-
sities summarized from individual time traces
when ermCL(S10F) is translated in presence of
erythromycin. Middle: the average number of Phe-
[Cy5]tRNAPhe binding events per codon. Right:
the average time the Phe-[Cy5]tRNAPhe stays
bound to the ribosome on each codon. Bars
represent single exponential fitting of the data ±
SEM (n = 84).
See also Figure S2.contains the Lys10 codon, the ribosome is not capable of stably
binding and accommodating Lys-tRNALys.
Other peptide sequences (e.g., ErmAL1 [Ramu et al., 2011])
cause erythromycin-induced stalls with an aa-tRNA selective A
site. To probe this possibility, we repeated the intersubunit
FRET/TC binding experiment with [Cy5]tRNAPhe rather than
[Cy5]tRNALys, using an ermCL(S10F) mRNA mutant. The two
Phe codons located upstream from the stall site (Phe4
and Phe7) act as an internal control for tRNA transit pulses
during normal elongation. In striking contrast to translation of
ermCL(S10K) with Lys-tRNALys, Phe-tRNAPhe binding is
observed on all three Phe codons, including Phe10 (Figure 3C).
The [Cy5]tRNAPhe dwell time is the same on the Phe10 stall
codon as the other two (13–17 s), but the binding events are
most likely unproductive because several [Cy5]tRNAPhe binding
events occur (3.7 ± 1.3 on average) at this codon (Figure 3C).
Thus, accessibility and stability of the A-site-tRNA interactions
for macrolide-stalled ribosomes on ermCL depends on the
sequence of the stall site itself.
The stalled ribosome has completed translocation of the Ile9
codon to the P site, but the [Cy5]tRNALys and [Cy5]tRNAPhe
experiments suggest that this back-rotated ribosome confor-
mation is perturbed in A-site aa-tRNA binding and/or accommo-
dation. One possibility could be that the peptidyl-tRNA, now
reaching far into the drug-obstructed tunnel, is prevented from
proper translocation into the P site, and hence that intersubunit
rotation andmRNA/tRNAmovements are decoupled. TomonitorCtranslocation directly, we tracked deacylated tRNAVal occu-
pancy at the Val8 codon, which during proper translocation
should dissociate rapidly once positioned in the ribosomal E
site (Uemura et al., 2010). When Cy3-labeled Val-tRNAVal was
delivered together with a DVal aa-tRNA mix and [Cy5]50S sub-
units to immobilized [Cy3.5]30S PICs (Figure 4A), the lifetimes
of the Cy3 pulses, representing the time the tRNAVal stays bound
to the ribosomes, were the same in presence and absence of
erythromycin (7.5 ± 0.7 and 7.1 ± 0.5 s, respectively, Figure 4B).
This result shows rapid eviction of tRNAVal when the ribosome
reaches the stall site, and thus suggests translocation of the
mRNA and tRNA molecules on the ribosome. The time to trans-
late themessage up to the first [Cy3]tRNAVal signal (Val8) was the
same with or without drug (107 ± 10 and 100 ± 7 s, respectively),
and the time between the arrival of the first and second [Cy3]
tRNAVal in absence of drugwas 62 ± 8 s (Figure 4C). These values
agree with translation rates derived from individual codon life-
times using the intersubunit FRET signal (Figure 1E).
Translation of the h-ns Readthrough mRNA Involves
a Pause in the Rotated State
The sequence of the nascent chain determines its sensitivity to
erythromycin (Kannan et al., 2012). Peptide sequences that are
resistant to macrolide action may allow the peptide to sneak
past the tunnel-bound macrolide. To investigate readthrough in
the presence of macrolides, we prepared an mRNA consisting
of the first 12 codons of the h-ns ORF, which is sufficient toell Reports 7, 1534–1546, June 12, 2014 ª2014 The Authors 1539
Figure 4. tRNAVal Proceeds Normally
through the Ribosome on the Val8 Codon
upon Reaching the Erythromycin-Induced
Stall on ermCL
(A) The interaction of tRNAVal with the ermCL
programmed ribosome was followed by delivering
DVal aa-tRNA-containing TCs, together with Val-
[Cy3]tRNAVal and [Cy5]50S to immobilized [Cy3.5]
30S PICs. The time trace shows how in the
absence of erythromycin the [Cy5]50S subunit
joining to an immobilized [Cy3.5]30S PIC is fol-
lowed by two [Cy3]tRNAVal binding events, pre-
sumably on the Val8 and Val12 codons.
(B) The average time [Cy3]tRNAVal spends bound
to the ribosome in absence (n = 170) or presence
(n = 81) of erythromycin, summarized from indi-
vidual time traces. Bars represent single expo-
nential fitting of the data ± SEM.
(C) The average arrival time for [Cy3]tRNAVal, in
absence (n = 170) or presence (n = 81) of erythro-
mycin. The arrival times represent the time to
translate theermCLmessageuptocodonsVal8and
Val12 (the latter only in absence of erythromycin)
starting from subunit joining (see A). Bars represent
single exponential fitting of the data ± SEM.rescue full-length protein synthesis when fused N-terminally to
other genes (Kannan et al., 2012), followed by a Lys-Phe-STOP
sequence (Figure 5A). A Cy3B/BHQ intersubunit FRET experi-
ment in the presence of erythromycin shows that readthrough
of erythromycin-induced termination can occur: a large fraction
(18%) of ribosomes reach the stop codon (Figure 5B). In contrast
to the experiments with the ermCL variant mRNAs in the pres-
ence of macrolide, the lifetimes of the nonrotated state are fairly
constant and low throughout the whole message. Instead, trans-
lation of h-ns in the presence of erythromycin shows prolonged
lifetimes of the rotated state, in particular during translocation
between Leu8 and Asn9 in A site (Figures 5A, 5B, and S3A).
Low-level readthrough of h-ns in the presence of erythromycin
was confirmed in the bulk translation assay similar to what was
done for the ermCL variants. For h-ns the incorporation of
[3H]Phe into peptides was used to monitor full-length peptide
synthesis (Figure S3B), yielding approximately 40% full-length
product in presence of the drug compared to the control exper-
iment performed in absence of drug.
To characterize the elongation dynamics of h-ns readthrough
in the presence of macrolides, we used Cy3B/BHQ inter-
subunit FRET correlated to the arrival of Phe-[Cy5]tRNAPhe.
Because a unique Phe codon was inserted adjacent to the
stop codon, colocalized Cy3B and Cy5 fluorescence indicates
ribosomes that have translated past the potential pause site
(Figure 5C). The lifetimes of the rotated and nonrotated state
that are estimated from this experiment confirm the results
obtained from the previous Cy3B/BHQ experiment, with
unlabeled tRNAs, but now with better precision in the codon
assignment due to the [Cy5]tRNAPhe benchmark signal (Fig-1540 Cell Reports 7, 1534–1546, June 12, 2014 ª2014 The Authorsure 5D). The lifetimes of the nonrotated
state are fairly constant throughout the
message and do not differ significantlyfrom the times obtained when the same experiment is per-
formed in absence of drug. The lifetimes of the rotated state
in the presence of the drug are the same as in the absence
of drug except with the Leu8 in A site, where the lifetime is
extended significantly (19 ± 4 s compared to 4.8 ± 1.4 s in
absence of drug, or 6.2 ± 0.7 s on average on the other
codons). After this pause, the ribosome continues elongating
the H-NS peptide with no obvious perturbation. Interestingly,
the other Leu codon, at position 5, shows a prolonged lifetime,
although to a lesser extent (10 ± 2 s). Increasing the concentra-
tion of erythromycin 4-fold (4 mM) or decreasing it 2-fold
(0.5 mM) did not change the H-NS elongation dynamics signif-
icantly (Figure S3C).
As with ErmCL stalling, the long pause in the rotated state at
codon 8 of h-ns mRNA in the presence of erythromycin is not
changed by increased factor concentrations. We repeated the
Cy3B/BHQ intersubunit FRET experiment on h-ns using Phe-
[Cy5]tRNAPhe in presence and absence of erythromycin, now
with 8-fold higher TC concentration (12 mM DPhe aa-tRNA) and
4-fold higher EF-G concentration (640 nM). In the absence of
drug, as expected, the lifetimes of the nonrotated state
decreased proportionally (9.5 ± 0.9 to 1.5 ± 0.3 s on average)
except on the first codon where the dissociation of IF2 after sub-
unit joining takes approximately 2 s irrespective of TC concentra-
tion (Tsai et al., 2012) (Figure S3D). The lifetimes of the rotated
state did not completely scale with concentration (4.2 ± 0.4 s
at low to 2.2 ± 0.2 s at high concentrations on average) suggest-
ing a maximal translocation rate of 0.75 s1 under these experi-
mental conditions. Comparing the overall time from subunit
joining to the Cy5 signal (representing the time to read 11
Figure 5. Erythromycin Readthrough on
h-ns Involves a Pause in the Rotated State
at Codon Leu8
(A) The dynamics of h-ns(1-12)_FK translation in
presence of erythromycin was followed in real time
using intersubunit FRET between Cy3B and BHQ.
Full-length synthesis of the H-NS peptide involves
a pause in the rotated state after reading the Leu8
codon.
(B) Left: survival plot summarized from individual
h-ns(1-12)_FK translation time traces in presence
of erythromycin. Right: lifetimes of the rotated and
nonrotated state for each individual codon during
h-ns(1-12)_FK translation in presence of erythro-
mycin. Bars represent single exponential fitting of
the data ± SEM (n = 138).
(C) Dynamics of h-ns(1-12)_FK translation, as
followed by intersubunit FRET and simultaneous
Phe-[Cy5]tRNAPhe binding. The time trace shows
how one ribosome translates the 14 codon h-ns(1-
12)_FK message, followed in real time by Cy3B/
BHQ intersubunit FRET, whereas the Cy5 signal
reports on the binding of Phe-tRNAPhe on codon
Phe13. The experiment was performed in the
presence of DPhe aa-tRNAs.
(D) Lifetimes of the rotated and nonrotated state
for each individual codon during h-ns(1-12)_FK
translation in presence (n = 51) or absence (n = 26)
of erythromycin. Colocalized [Cy3B]30S and [Cy5]
tRNAPhe signals were used to select and include
ribosomes reaching at least the Phe13 codon.
Bars represent single exponential fitting of the
data ± SEM.
See also Figure S3.codons) between experiments at high (Figure S3E) and low fac-
tor (Figure 5C) concentrations and in the presence or absence of
drug, it is apparent that the slow translation of h-ns in the pres-
ence of erythromycin is not rescued by higher factor concentra-
tions (Figure S3F).
To investigate whether the pause in the rotated state on h-ns
is a general feature linked to elongation through an erythro-
mycin-obstructed tunnel, we translated another mRNA
N-terminal sequence reported to rescue translation of erythro-
mycin sensitive sequences, the first 18 codons of hspQ
(Kannan et al., 2012). In the presence of 1 mM erythromycin,
no full-length synthesis was observed (Figure S3G). However,
a very long pause in the rotated state at codon Ile8 resembles
the similar pause at the Leu8 codon in h-ns. Thus elongation of
the HspQ N-terminal sequence also clearly displays the same
kinetic signature as achieved with h-ns translation in presence
of erythromycin.Cell Reports 7, 1534–154EF-G Does Not Efficiently Resolve
the Rotated-State Pause at Leu8
in h-ns
We calculated Cy3B-Cy5 FRET values
on each individual codon when repeating
the h-ns intersubunit FRET experiment in
the presence of erythromycin using Cy5-
rather than BHQ-labeled 50S subunits(Figure 6A). Averaging over the first five codons, the low- and
high-FRET values fit very well to single Gaussian distributions
with averages of 0.36 and 0.5, respectively. The stalled state is
well described by the low-FRET state, with some mixing of
high-FRET, perhaps due to short-lived transitions to the nonro-
tated state (Figure 6B).
By using Cy5-labeled EF-G in conjunction with the Cy3B/BHQ
intersubunit FRET signal, we can track the ribosome intersubunit
rotations as the ribosome moves stepwise on the mRNA and,
simultaneously, observe the Cy5 pulses as EF-G engages the
ribosome, catalyzing translocation, resulting in back-rotation of
the subunits and a low-to-high Cy3B/BHQ-FRET transition (Fig-
ure 6C). With this methodology, we can determine the time EF-G
spends bound to the ribosome, and number of binding events,
on each codon (Chen et al., 2013). To allow detection of labeled
EF-Gbinding events at high factor concentrations, the experiment
was conducted in zero-mode waveguides (ZMWs) rather than on6, June 12, 2014 ª2014 The Authors 1541
Figure 6. Characterization of the Pause
State on h-ns
(A) The dynamics of h-ns(1-12)_FK translation in
presence of erythromycin was followed in real time
using intersubunit FRET between Cy3B and Cy5.
(B) Upper: FRET distributions calculated from
rotated and nonrotated state on codons Ser2 to
Lys6 from time traces as shown in (A). Lower:
FRET distribution calculated from the pause on
Leu8 codon (n = 41).
(C) Cross-correlated [Cy5]EF-G binding and
intersubunit FRET (Cy3B and BHQ). EF-G binding
events are correlated with the transition back
from the rotated to the nonrotated state of the
ribosome.
(D) Upper: average number of EF-G binding events
on the respective codons of h-ns(1-12)_FK, as
calculated from individual time traces as shown in
(A). Lower: average EF-G dwell time on the
respective codons of h-ns(1-12)_FK, as calculated
from individual time traces as shown in (A). Bars
represent single exponential fitting of the data ±
SEM (n = 117).
See also Figure S4.the TIRF set-up, because ZMWs allow much higher dye-labeled
ligand concentrations in the solution (Chen et al., 2014; Uemura
et al., 2010). Hence, h-ns [Cy3B]30S-PICs were immobilized on
a chip of ZMWs onto which a mixture of total TCs, [BHQ]50S,
and [Cy5]EF-G was delivered (Figure S4A). The number of EF-G
binding events per translocation (Figure 6D) was approximately
one on most codons, as observed previously (Chen et al., 2013),
but an increased number of binding events was observed during
the long pause at Leu8 (3.0 ± 0.4 binding events on average).
The average time EF-G spent bound to the ribosome was the
same on all codons (200 ms), and the dwell times on codon
Leu8 was, as during normal translocation (Chen et al., 2013),
best fitted to a three step model (Figure S4B). Thus, EF-G binds
normally to the long-lived rotated pause state at codon Leu8 of
the h-ns mRNA, but on average three EF-G binding attempts
that probably involve GTP hydrolysis are needed before trans-
location and back-rotation of the subunits occurs successfully.
DISCUSSION
Despite decades of research and clinical use, a detailed mecha-
nistic explanation for the bacteriostatic effects of macrolides is1542 Cell Reports 7, 1534–1546, June 12, 2014 ª2014 The Authorslacking. High-resolution crystal struc-
tures of the ribosomal nascent peptide
exit tunnel and complexes with macro-
lides (Bulkley et al., 2010; Dunkle et al.,
2010; Schlu¨nzen et al., 2001; Tu et al.,
2005) suggested that the traditional
model for macrolide action involving full
steric blocking of the exit tunnel is likely
incorrect, because there is enough space
between the drug and the tunnel wall for
peptides to pass by. The recent observa-
tions of ribosome stalling or readthroughin the presence of macrolides strongly suggest a complex inter-
play of drug, nascent-peptide chain, and ribosome during trans-
lation (Kannan et al., 2012). To gain insight into the determinants
of these stochastic, highly dynamical processes, we used fluo-
rescence-based assays developed in our group for real-time
tracking of single translating ribosomes. The system has been
used extensively to track various aspects of protein synthesis
(e.g., Chen et al., 2013; Tsai et al., 2012; Uemura et al., 2010),
including elongation dynamics during SecM stalling (Tsai et al.,
2014). In the present study, we applied this system to unravel
the mechanisms of inhibition by macrolides during translation
of several different mRNAs.
We first reproduced the features of ribosome stalling on the
well-studied short leader ORF in the ermC cassette, ermCL. In
absence of drug, the 19 codon ermCL message is translated
to the stop codon with a relatively constant rate (Figures 1C
and 1E). In the presence of erythromycin, our single-molecule
measurements on ermCL agree with results from ensemble ex-
periments—elongation is severely inhibited and a relatively large
fraction of the ribosomes stop specifically at the previously pro-
posed stalling site, with the Ser10 codon in A site. The stall oc-
curs in a nonrotated state, also consistent with the observation
that the stalled ribosomes are not capable of catalyzing peptidyl
transfer to Ser-tRNASer (Vazquez-Laslop et al., 2008). The small
fraction of ribosomes reaching beyond the stall site (7% reaching
codon Val12) implies that stalling is not complete but could also
be explained by codon-to-codon uncertainty in assignments
and/or the possibility that the drug molecule dissociates.
The observations of stalling observed in our system are inde-
pendent of translation rate. In our experimental set-up, the
lifetimes of the nonrotated and rotated states during normal
elongation represent mainly the waiting times for TC and EF-G
to arrive, respectively. The factor concentrations were tuned to
balance on one hand the need to translate fast enough to see
full-length synthesis during the photobleaching limited dye life-
time, and on the other hand slow enough for us to be able to
separate individual state transitions. We have addressed the
potential problems due to this discrepancy with in vivo
elongation rates (0.07–0.3 s1 in our assays versus 5 s1 at
20C in vivo) (Ryals et al., 1982) by showing that elevated
factor concentrations do not affect the pausing/stalling events
investigated.
Comparing the results achieved with ermCL to the results from
a more general mRNA, gp32, the ErmCL N terminus allows
elongation of a longer nascent peptide (46% and 13% reaching
codon 10 on ermCL and gp32, respectively) in presence of eryth-
romycin. The lifetimes of the nonrotated and rotated state are
fairly similar between the two mRNAs except for the long
pause/stall at codon Ser10 on ermCL. Whereas the stall on
ermCL occurs in the nonrotated state, the end state on gp32
seems to be equally distributed between rotated and nonro-
tated. Inhibition of peptide elongation by macrolides causes
peptidyl-tRNA drop-off (Menninger and Otto, 1982). In our
present analysis, we cannot tell if or when peptidyl-tRNA disso-
ciates from the ribosome. However, similar lifetimes of the non-
rotated state on early codons in elongation of ErmCL and GP32
in the presence of erythromycin on one hand, and ErmCL in the
presence or absence of the drug on the other hand, both suggest
that increased peptidyl-tRNA drop-off would not be caused by
prolonged waiting times. Rather, the tunnel-bound drug might
prevent stabilizing contacts between the peptide and the tunnel
wall, accelerating peptidyl-tRNA drop-off in a peptide sequence-
dependent manner. The fact that no stalling was seen on erm-
CL(I9A) in prior toe-print assays (Vazquez-Laslop et al., 2008),
although elongation is still terminated prematurely (Figure S1D),
suggests that this minor change to the peptide sequence results
in an elongation halt, now due to peptidyl-tRNA drop-off rather
than the formation of a stable stalled complex.
Our results underscore the dynamic nature of the drug-
nascent chain-tunnel interaction. Incorporation of the first seven
to eight amino acids on ermCL are not kinetically altered by the
presence of erythromycin, despite the fact that the growing pep-
tide should have already encountered the tunnel-bound drug
molecule after a tri- or tetrapeptide has been synthesized (Tu
et al., 2005). Unhindered elongation of these first eight amino
acids in the presence of drug is additionally supported by the
decrease in lifetimes of the nonrotated state with higher TC con-
centration, at least up to codon Val8, and similar dwell times of
[Cy5]tRNAVal in presence or absence of erythromycin. Ribo-
somes in the presence of macrolide can thus translate up toCcodon 10 in the A site with normal elongation rates, limited in
our experiments by TC and EF-G concentrations. Upon reaching
the codon Ser10, further elongation is blocked. Macrolide-
mediated stalling of elongation is abrupt, in contrast to the
gradual slowdown and heterogeneous stall positions observed
in SecM-mediated stalling (Tsai et al., 2014).
Our results agree with prior biochemical experiments that
clearly showed ribosomes translating ermCL stalled with codon
Ser10 in the A site, but before peptidyl transfer to a Ser-tRNASer
(Vazquez-Laslop et al., 2008). The stalled complex did not react
with puromycin, with stalling attributed to a disrupted PTC. Our
analysis of cross-correlated intersubunit FRET and tRNA binding
showed almost no stable A-site binding of [Cy5]tRNALys in the
stalled complex when the A-site codon was changed to Lys
(ermCL(S10K)), whereas a Phe10 codon in A site (ermCL(S10F)
was available to [Cy5]tRNAPhe. Because the steps following TC
binding up to GTP hydrolysis are much faster, 120 s1 (Johans-
son et al., 2008), than the temporal resolution of our analysis (30–
100 ms), we speculate that Lys-[Cy5]tRNALys TC can bind to the
ribosome and may hydrolyze EF-Tu-bound GTP, but that Lys-
tRNALys cannot accommodate properly into the 50S A site and
therefore rapidly falls off, leading to sampling pulses shorter
than our time resolution. Phe-[Cy5]tRNAPhe on the other hand
reaches a more stable state, possibly an accommodated one,
but dissociates before peptidyl transfer can occur, leaving the
A site available for a new Phe-tRNAPhe to bind. In agreement
with these trends, Phe and Lys were the least and most stalling
efficient A-site codons, respectively, on the ermAL1 stalling
ORF (Ramu et al., 2011). Whereas ermCL(S10F) elongation is still
efficiently terminated (Figure S2B), this observation suggests
that the ermCL-stalled complex also has a selective A site,
similar to the ermAL1-stalled complex, and that the selectivity
lies in accommodation of the aa-tRNA rather than in the peptidyl
transfer reaction. This possibility was previously broached
(Ramu et al., 2011), regarding amino acid dependence in aa-
tRNA accommodation pathways (Whitford et al., 2010). Results
from the characterization of ermAL1 stalling together with our
findings would thus suggest that amino acids with hydrophobic
side chains accommodate more easily into or are stabilized at
the PTC. The ermCL wild-type Ser10 codon has an intermediate
stalling efficiency on ermAL1 and would likely have intermediate
A-site accommodation efficiency on ermCL.
Elongation of the H-NS readthrough peptide showed a unique
dynamic signature in the presence of erythromycin. As with
ermCL, there is a long-lived pause during elongation in the
presence of macrolide, but now in the rotated ribosomal state
after incorporation of Leu8. After approximately three transloca-
tion attempts by EF-G, the ribosome is reset and translocates
and then continues translating the message with no inhibition
of subsequent elongation steps, i.e., as with no drug bound.
Because EF-G binds normally to the paused h-ns complex
(with normal dwell time and time distribution, but with an
elevated number of binding events required), it is likely that the
A-site peptidyl-tRNA ismoved properly into the hybrid state sub-
sequent to peptidyl transfer. However, the pause time is not
dependent on EF-G concentration (the difference between the
overall elongation times in presence and absence of drug did
not decrease at high factor concentration). This suggests aell Reports 7, 1534–1546, June 12, 2014 ª2014 The Authors 1543
Figure 7. Proposed Model for Sequence-Specific Effects of Peptide Elongation through an Erythromycin-Bound NPET
Although the rate of peptide elongation is not affected by the presence of erythromycin in the NPET, stabilizing contacts between the nascent peptide and the
tunnel are disrupted resulting in accelerated peptidyl-tRNA drop-off on early codons. Certain peptides can proceed with higher probability but interactions with
the drug and the tunnel eventually lead to a halt in translation. Whereas stalling peptides induce a blockage of the PTC resulting in a stable stalled complex,
readthrough peptides stabilize peptidyl-tRNA in the rotated state of the ribosome long enough for structural rearrangements within the tunnel to occur allowing
resumed translation.significant translocation barrier and suggests that movement of
the peptidyl-tRNA from A site to P site during translocation
involves movement of the nascent peptide inside the tunnel,
and that these peptide movements are hindered by the tunnel-
bound drug.
Our results lead to a model for readthrough of ribosomes dur-
ing synthesis of specific nascent peptides in the presence of
macrolides. After synthesis of an octapeptide (H-NS), transloca-
tion is blocked, but specific interactions among the nascent
peptide, drug, and tunnel stabilizes peptidyl-tRNA long enough
for structural rearrangements to occur so that elongation can
resume. The most straightforward hypothesis would be that
the paused state is resolved by erythromycin dissociation. How-
ever, increasing the concentration of erythromycin 4-fold, which
would potentially make reassociation of the drug four times
faster, did not alter the pause time. Moreover, in Kannan et al.
(2012) it was cleverly shown, by fusing ermCL 30 to h-ns, that,
despite readthrough on h-ns, the ribosome would still stall on
the 30 fused ermCL, suggesting that erythromycin is still bound
inside the tunnel. Although the drug molecule could be first
evicted and then rebind at a later stage, these observations
strongly suggest that the H-NS peptide is capable of bypassing
the tunnel-bound drug (Kannan et al., 2012). In the macrolide-
bound ribosomes, the space available for the peptide to pass
through the tunnel is limited by the drug and the highly flexible
nucleotide A2062 (Fulle and Gohlke, 2009). Thus, the observed
pause could be due to a reorganization within the tunnel, e.g.,
moving the A2062 base toward the tunnel wall (Kannan et al.,
2012), allowing complete movement of the peptidyl-tRNA to
the P site, subsequent back-rotation of the subunits and further
peptide elongation.
In conclusion, our results show how elongation dynamics for a
macrolide-obstructed NPET aremodified by the sequence of the
nascent peptide (Figure 7). Peptide elongation rates are not
severely inhibited in general by the presence of the macrolide in-
side the NPET, but stalls (ermCL) or pauses (h-ns) are abrupt,1544 Cell Reports 7, 1534–1546, June 12, 2014 ª2014 The Authorssequence-specific events. The cause of increased peptidyl-
tRNA drop-off in the presence of the macrolide (Tenson et al.,
2003) is likely not due to increased waiting time. Rather, the
drug may disrupt necessary stabilizing contacts between the
nascent peptide and the tunnel resulting in higher probability of
elongation abortion due to peptidyl-tRNA drop-off. Certain
peptides, such as ErmCL, H-NS, or HspQ, might be sufficiently
stable in presence of bound macrolide and hence can bypass
the drug with a higher probability than a general peptide, such
as GP32. Whereas elongation of the stall peptides eventually
leads to perturbation of the A site preventing proper alignment
of the aa-tRNA into the PTC, the readthrough peptides likely
cause rearrangements within the tunnel that allow continuation
of elongation after the pause. Further structural and dynamics
experiments will be needed to correlate drug occupancy with
nascent peptide interactions and elongation dynamics.
Our results underscore the power of single-molecule methods
to provide real-timemonitoring of complex biological processes.
The ability to track single elongating ribosomes in real time on
complexmRNAswill permit further investigations of how elonga-
tion rates are regulated during translation by mRNA and nascent
protein sequence, folding, and structure.
EXPERIMENTAL PROCEDURES
Reagents and Buffers
Fluorescently labeled, or wild-type ribosomal subunits, IF2, ribosomal protein
S1, fluorescently labeled tRNAs, and unlabeled fMet-tRNAfMet were prepared
as previously described (Blanchard et al., 2004; Dorywalska et al., 2005;
Marshall et al., 2008). Biotinylated mRNAs were either purchased (6(FK)
from Dharmacon) or prepared by hybridizing the 50 UTR of in-house tran-
scribed and purified mRNAs (for gp32: [McKenna et al., 2007], all others:
[Johansson et al., 2012]) to a biotinylated DNA splint oligo (see Supplemental
Experimental Procedures for sequences). A semipurified mix of aminoacyl-
tRNA synthetases was prepared from E. coli S30 extract according to (Pavlov
and Ehrenberg, 1996). Total or D(Lys, Val or Phe) aa-tRNAs were prepared by
incubating total E. coli tRNA (Sigma) with all amino acids (minus Lys, Val, or
Phe forDmixes) together with the crude aaRSmix for 30min at 37C in a buffer
consisting of Tris-HCl (50mM [pH 7.5]), KCl (50mM),MgCl2 (10mN), and b-ME
(3mM), complementedwith ATP (2mM), phosphoenol pyruvate (PEP, 10mM),
pyruvate kinase (PK, 50 mg/ml), myokinase (MK, 2 mg/ml), and inorganic
pyrophosphatase (PPiase, 10 mg/ml). aa-tRNAs were thereafter purified by
phenol extraction, ethanol precipitation, and gel filtration (Bio-Gel P-6 column,
Bio-Rad) and finally stored in small aliquots at 80C. All experiments were
conducted at room temperature in a Tris-based polymix buffer consisting of
50 mM Tris-OAc (pH 7.5), 100 mM KCl, 5 mM NH4OAc, 0.5 mM CaOAc,
5 mM MgOAc, 0.5 mM EDTA, 5 mM putrescine, and 1 mM spermidine.
Single-Molecule Experiments on TIRF Microscope
Dye labeling of ribosomal subunits were always performed immediately before
the experiments according to (Marshall et al., 2008). [Cy3B]30S PICs were
formed by preincubating (5 min at 37C) the labeled subunit (0.25 mM) with
S1 (0.25 mM), IF2 (1 mM), fMet-tRNAfMet (1 mM), and 50 biotinylated mRNA
(1 mM) in polymix buffer supplemented with GTP (4mM). The PICs were diluted
(20- to 200-fold) in polymix buffer containing IF2 (1 mM) and GTP (4 mM) and
immobilized on the surface of a biotin-PEG derivatized quartz slide via
biotin-neutravidin interactions. Excess unbound material was washed away
with polymix supplemented with IF2 (1 mM), GTP (4 mM), and an oxygen
scavenging system consisting of Trolox (1 mM), 3,4-dihydroxybenzoic acid
(2.5 mM), and protocatechuate deoxygenase (250 nM).
Total or D(aa) aa-tRNA,EF-Tu,GTP ternary complexes were preformed by
incubating briefly (2 min at 37C) the aa-tRNAs with 5-fold excess of EF-Tu,
GTP (1 mM), PEP (3 mM), and EF-Ts (40 mM) in polymix. The TCs (final con-
centration in reaction 1.5–12 mM) were added to dye-labeled 50S (typically
100 nM), EF-G (80–640 nM), IF2 (1 mM), GTP (4 mM), erythromycin (1 mM,
when applicable), and the oxygen scavenging system to form a delivery mix
in polymix buffer. To initiate translation elongation on the immobilized PICs,
the delivery mix was added to the quarts slide through a computer controlled
syringe pump.
The instrumental set-up consisted of a prism-based total internal reflection
fluorescence microscope as previously described (Tsai et al., 2013). For exci-
tation of Cy3B, a diode-pumped solid-state 532 nm laser at 1 kW cm2 was
used, and for Cy5, when applicable, a 647 nm laser at 400 W cm2 was
used. Videos were recorded (typically at 10 fps with a total of 3,600 frames
collected) using the MetaMorph software package (Molecular Devices) and
fluorescent traces were extracted using in-house MATLAB (MathWorks)
scripts. Intersubunit FRET states and Cy5 ligand (tRNALys, tRNAPhe) binding
events were assigned manually from productive traces showing stable
[Cy3B]30S immobilization, joining of 50S (yielding high-FRET), and the high-
low-high-FRET cycle signaling intersubunit rotation. Average lifetimes for the
intersubunit FRET states were calculated only from productive states (i.e.,
low-FRET states that was followed by a high-FRET state and vice versa) to
eliminate artifacts from photophysical effects.
Single-Molecule Experiments on ZMWs
[Cy3B]- or [Cy3.5]30S PICs were prepared as described for the TIRF experi-
ments and immobilized through biotin-neutravidin linkage on chips containing
75,000 individual ZMWs with an average diameter of 130 nm (Chen et al.,
2014). The delivery mixes were prepared as described for the TIRF experi-
ments except for the use of Cy5-labeled EF-G (160 nM) for the experiment
shown in Figure 6C or Val-[Cy3]tRNAVal with a DVal aa-tRNAmix for the exper-
iment in Figure 4A. Cy3B, Cy3.5, and Cy5 fluorescence was detected using
direct excitation with lasers at 532 and 632 nm and laser power of 0.48 mW/
mm2 and 0.22 mW/mm2, respectively. Fluorescence intensity was recorded
from all ZMWs during 6 min at 10 fps, and time traces were selected and
analyzed from ZMW wells containing exactly one immobilized Cy3B or
Cy3.5 molecule using a similar set of MATLAB scripts as was used for the
TIRF experiments.
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